MOUNTAINEER: Open-label, phase 2 study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017, trial in progress) Meeting Abstract
| Authors: | Siena, S.; Elez, E.; Peeters, M.; André, T.; Van den Eynde, M.; Ng, K.; Cercek, A.; Fountzilas, C.; Sanchez, F.; Hubbard, J.; Wu, C.; Tabernero, J.; Kardosh, A.; Saeed, A.; Strickler, J.; Bekaii-Saab, T.; Stecher, M.; Palanca-Wessels, M.; Van Cutsem, E. |
| Abstract Title: | MOUNTAINEER: Open-label, phase 2 study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017, trial in progress) |
| Meeting Title: | ESMO 23rd World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2021 Jun 30-Jul 3 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-07-01 |
| Start Page: | S199 |
| Language: | English |
| ACCESSION: | WOS:000670004200294 |
| DOI: | 10.1016/j.annonc.2021.05.019 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: PD-1 -- Source: Wos |
